SCA
ABMD

SAC Capital Advisors’s Abiomed Inc ABMD Stock Holding History

SAC Capital Advisors’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-11,972
Closed -$312K – 1149
2014
Q1 		$312K Buy
+11,972
New +$331K ﹤0.01% 1390
2013
Q4 		– Sell
-15,457
Closed -$295K – 2037
2013
Q3 		$295K Buy
15,457
+13,157
+572% +$301K ﹤0.01% 1408
2013
Q2 		$50K Buy
+2,300
New +$46.2K ﹤0.01% 1597

Other funds holding ABMD

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return

SAC Capital Advisors's ABMD Position: Q2 2014 in Review

SAC Capital Advisors sold out of Abiomed Inc (ABMD) in Q2 2014, closing a stake of 11,972 shares — an estimated $312K sold.

SAC Capital Advisors first reported a position in ABMD in Q2 2013 and held it in 3 quarters. The position peaked at $312K in Q1 2014. 138 funds tracked by Wall St. Rank hold ABMD as of Q2 2014.

  • SAC Capital Advisors reported no remaining Abiomed Inc position as of Q2 2014 after selling out during the quarter.
  • SAC Capital Advisors sold 11,972 Abiomed Inc shares in Q2 2014, an estimated $312K.
  • SAC Capital Advisors first reported a position in Abiomed Inc in Q2 2013 and held it in 3 quarters.
  • SAC Capital Advisors's Abiomed Inc position peaked at $312K in Q1 2014.
  • 138 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2014.

Based on SAC Capital Advisors's 13F filing for Q2 2014.